Clinical Trial Update: Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the safety of trifluridine/tipiracil (Lonsurf) in patients with dihydropyrimidine dehydrogenase (DPD) deficiency who have metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Dihydropyrimidine Dehydrogenase Deficiency
• Gastroesophageal Adenocarcinoma

Drugs mentioned

• Lonsurf (Trifluridine/Tipiracil) (Trifluridine/Tipiracil)

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Colorectal Cancer, Metastatic Gastroesophageal Adenocarcinoma | Phase 2 | Status: RECRUITING